Study guide
3.3 Diabetes Mellitus, Thyroid Disorders & Adrenal Axis Pathologies
Saudi Medical Licensing Examination SMLE
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Overview & Foundation of Clinical Practice
1.1 Exam Format, Blueprint & Preparation Strategy 1.2 Medical Bioethics, Patient Safety & SCFHS Regulations 1.3 Biostatistics & Clinical Epidemiology in Saudi Healthcare
2 Chapter 2: Internal Medicine - Cardiovascular & Respiratory Systems
2.1 Coronary Artery Disease, Dysrhythmias & Heart Failure 2.2 Respiratory Failure, Asthma, COPD & Infiltrative Lung Diseases 2.3 Critical Care Medicine, Shock Syndromes & Mechanical Ventilation
3 Chapter 3: Internal Medicine - Gastroenterology, Renal & Endocrine Systems
3.1 Hepatobiliary Disorders, Peptic Ulcers & Inflammatory Bowel Disease 3.2 Acute Kidney Injury, Chronic Kidney Disease & Electrolyte Imbalances 3.3 Diabetes Mellitus, Thyroid Disorders & Adrenal Axis Pathologies
4 Chapter 4: Internal Medicine - Infectious Diseases, Hematology & Subspecialties
4.1 Saudi Regional Infections (MERS-CoV, Brucellosis, TB, Dengue) & Antimicrobial Therapy 4.2 Hemoglobinopathies (Sickle Cell & Thalassemia), Anemias & Hematologic Malignancies 4.3 Connective Tissue Diseases, Stroke, Epilepsy & Movement Disorders 4.4 Psychiatry, Geriatrics & Behavioral Health
5 Chapter 5: Obstetrics - Antepartum & Intrapartum Care
5.1 Routine Prenatal Care, Screening & Fetal Assessment 5.2 Placental Disorders, Bleeding in Pregnancy & Isoimmunization 5.3 Normal Labor, Malpresentation, Operative Delivery & Fetal Monitoring
6 Chapter 6: Obstetrics - High-Risk Complications & Postpartum Care
6.1 Preeclampsia, Eclampsia & HELLP Syndrome 6.2 Preterm Labor, Premature Rupture of Membranes & Cervical Insufficiency 6.3 Postpartum Hemorrhage, Puerperal Infections & Maternal Mortality
7 Chapter 7: Gynecology & Reproductive Health
7.1 Menstrual Disorders, Endometriosis & Fibroids 7.2 Infertility Workup, Contraception & Menopause 7.3 Cervical, Uterine & Ovarian Neoplasms
8 Chapter 8: General Pediatrics, Neonatology & Development
8.1 Developmental Milestones, Growth Charts & Failure to Thrive 8.2 Saudi National Immunization Schedule & Well-Child Care 8.3 Neonatal Resuscitation, Jaundice, Respiratory Distress & Prematurity
9 Chapter 9: Pediatric Medicine - Respiratory, Cardiac & GI
9.1 Croup, Epiglottitis, Bronchiolitis, Asthma & Cystic Fibrosis 9.2 Congenital Heart Disease (Cyanotic & Acyanotic) & Rheumatic Fever 9.3 Dehydration, Gastroenteritis, Intussusception & Pyloric Stenosis
10 Chapter 10: Pediatric Medicine - Infections, Hematology, Emergencies & Subspecialty Systems
10.1 Exanthems, Meningitis, Sepsis & Febrile Seizures 10.2 Pediatric Sickle Cell Vaso-occlusive Crises, Thalassemia & ITP 10.3 Pediatric Trauma, Ingestion, Poisoning & Child Abuse Recognition 10.4 Pediatric Neurology, Nephrology & Musculoskeletal Disorders
11 Chapter 11: General Surgery & Surgical Principles
11.1 Preoperative Risk Assessment, Wound Healing & Surgical Infections 11.2 Fluid Resuscitation, Acid-Base Disturbances & Surgical Shock 11.3 Acute Abdomen, Appendicitis, Hernias, Gallbladder & Colorectal Surgery
12 Chapter 12: Trauma, Critical Care & Surgical Emergencies
12.1 ATLS Primary/Secondary Survey, Thoracic & Abdominal Trauma 12.2 Thermal/Chemical Burns, Parkland Formula & Wound Management 12.3 Breast Masses, Thyroid Nodule Evaluation & Surgical Oncology
13 Chapter 13: Surgical Subspecialties
13.1 Nephrolithiasis, BPH, Prostate Cancer & Increased Intracranial Pressure 13.2 Common Fractures, Compartment Syndrome & Pediatric Orthopedics 13.3 Epistaxis, Red Eye Emergencies, Peripheral Vascular Disease & Aortic Aneurysms
3.3 Diabetes Mellitus, Thyroid Disorders & Adrenal Axis Pathologies
Key Takeaways Explain This Topic AI
Metformin is the first-line pharmacotherapy for Type 2 Diabetes Mellitus; it acts primarily by decreasing hepatic gluconeogenesis and does not cause hypoglycemia.
Diabetic Ketoacidosis (DKA) requires aggressive IV fluid resuscitation (normal saline initially) followed by continuous IV insulin infusion; monitor and replete potassium carefully.
Primary hypothyroidism is characterized by an elevated TSH and low free T4; Hashimoto's thyroiditis (anti-TPO antibodies) is the most common cause.
Graves' disease, the most common cause of hyperthyroidism, presents with suppressed TSH, elevated free T4, and specific signs like exophthalmos and pretibial myxedema.
Addison's disease (primary adrenal insufficiency) presents with fatigue, hyperpigmentation, hypotension, hyponatremia, and hyperkalemia due to loss of both glucocorticoids and mineralocorticoids.
Last updated: July 2026
Diabetes Mellitus, Thyroid Disorders & Adrenal Axis Pathologies
Endocrinology constitutes a core high-yield domain on the SMLE, driven by the exceptional prevalence of Type 2 Diabetes Mellitus (~24% of the adult population) and metabolic syndrome in Saudi Arabia. Master diagnostic criteria, acute emergency resuscitation algorithms, thyroid functional panels, and adrenal diagnostic pathways.
- Diabetes Mellitus (DM): Diagnostic Criteria & Pharmacotherapy
- Diagnostic Thresholds (ADA & Saudi MOH Guidelines)
Diagnosis requires one of the following four criteria (confirmed by repeat testing on a separate day unless unequivocal hyperglycemia with acute metabolic decompensation is present):
Fasting Plasma Glucose (FPG): ≥126 mg/dL (7.0 mmol/L) after no caloric intake for at least 8 hours.
2-Hour Postprandial Glucose: ≥200 mg/dL (11.1 mmol/L) during an Oral Glucose Tolerance Test (OGTT using 75g anhydrous glucose).
Glycated Hemoglobin (HbA1c): ≥6.5% (48 mmol/mol).
Random Plasma Glucose: ≥200 mg/dL in a patient presenting with classic symptoms of hyperglycemia (polyuria, polydipsia, unexplained weight loss, blurred vision).
Pharmacotherapy for Type 2 Diabetes Mellitus
First-Line Therapy: Metformin (Biguanide). Decreases hepatic gluconeogenesis and increases peripheral insulin sensitivity. Weight-neutral, does not cause hypoglycemia as monotherapy. Major side effect: GI distress. Rare serious risk: Lactic acidosis . Contraindicated if eGFR <30 mL/min/1.73m².
Second-Line / Add-On Agents:
SGLT2 Inhibitors (Empagliflozin, Dapagliflozin): Block renal glucose reabsorption in proximal tubule. Proven reduction in CV mortality and heart failure hospitalizations; slows CKD progression . Side effects: Mycotic genital infections, euglycemic DKA.
GLP-1 Receptor Agonists (Liraglutide, Semaglutide): Enhance glucose-dependent insulin secretion, slow gastric emptying, promote significant weight loss. Proven CV benefit . Side effects: Nausea, pancreatitis risk. Contraindicated in Medullary Thyroid Carcinoma / MEN 2.
DPP-4 Inhibitors (Sitagliptin): Weight-neutral, low hypoglycemia risk. Do not combine with GLP-1 RAs.
Sulfonylureas (Gliclazide, Glimepiride): Stimulate pancreatic beta-cell insulin secretion. High risk of hypoglycemia and weight gain.
Acute Diabetic Emergencies: DKA vs. HHS
Diagnostic Parameter Diabetic Ketoacidosis (DKA) Hyperosmolar Hyperglycemic State (HHS)
Primary Patient Population Typically Type 1 DM (Absolute insulin deficiency). Typically Type 2 DM (Relative insulin deficiency; elderly).
Serum Glucose > 250 mg/dL (13.9 mmol/L). > 600 mg/dL (33.3 mmol/L).
Arterial / Venous pH < 7.30 (Severe metabolic acidosis). > 7.30 (Normal or mild acidosis).
Serum Bicarbonate < 18 mEq/L > 18 mEq/L
Anion Gap High Anion Gap (> 12 mEq/L) . Normal or mildly elevated.
Serum / Urine Ketones Strongly Positive (Beta-hydroxybutyrate). Absent or trace.
Effective Serum Osmolality Variable > 320 mOsm/kg (Severe hyperosmolality).
Dominant Clinical Signs Kussmaul breathing (deep, rapid respiration), fruity acetone breath, diffuse abdominal pain, nausea/vomiting. Profound dehydration, stupor, coma, focal neurological deficits.
Unified DKA/HHS Management Algorithm:
IV Fluid Resuscitation (Priority #1): Administer 1.0–1.5 L of 0.9% Normal Saline over the first hour to restore intravascular volume.
Insulin Therapy: Continuous IV regular insulin infusion (0.1 units/kg/hr). When glucose falls to ~200 mg/dL in DKA (or ~300 in HHS), add 5-10% Dextrose to IV fluids to prevent hypoglycemia while continuing insulin to clear ketoacidosis.
Potassium Management (CRITICAL): Total body potassium is depleted due to osmotic diuresis. Insulin drives potassium into cells:
If K+ <3.3 mEq/L: HOLD INSULIN ; give IV KCl until K+ >3.3 mEq/L.
If K+ 3.3–5.2 mEq/L: Add 20-30 mEq KCl per liter of IV fluid to maintain K+ between 4.0 and 5.0 mEq/L.
If K+ >5.2 mEq/L: Do not add K+ to fluids; recheck K+ every 2 hours.
- Thyroid Axis Dysfunction
- Primary Hypothyroidism
Labs: High TSH, Low Free T4. (Subclinical: High TSH, Normal Free T4).
Etiology: Hashimoto's Thyroiditis (chronic lymphocytic thyroiditis) is the most common cause. Marked by anti-thyroid peroxidase ( anti-TPO ) and anti-thyroglobulin antibodies. Histology: Lymphocytic infiltrate with germinal centers and Hürthle cells .
Presentation: Fatigue, cold intolerance, weight gain, constipation, dry skin, non-pitting periorbital edema, delayed relaxation of deep tendon reflexes.
Treatment: Levothyroxine (synthetic T4) . Take on an empty stomach 30-60 mins before breakfast. Monitor TSH at 6-8 weeks to adjust dosing.
Hyperthyroidism & Thyrotoxicosis
Labs: Low / Suppressed TSH (<0.01), High Free T4 / T3.
Graves' Disease: Most common cause. Caused by Thyroid-Stimulating Immunoglobulins (TSI) binding TSH receptors. Triad: (1) Thyrotoxicosis; (2) Exophthalmos (Proptosis) due to retro-orbital fibroblast glycosaminoglycan accumulation; (3) Pretibial Myxedema (infiltrative dermopathy).
Pharmacotherapy:
Symptom control: Beta-blockers ( Propranolol blocks peripheral T4 to T3 conversion).
Antithyroid Drugs (Thionamides): Methimazole (first-line in non-pregnant patients; teratogenic in 1st trimester causing aplasia cutis). Propylthiouracil (PTU) (first-line in 1st trimester of pregnancy and in Thyroid Storm because it inhibits peripheral T4 to T3 conversion). Major rare side effect of both: Agranulocytosis (fever + sore throat mandates immediate CBC).
Thyroid Storm Management: Beta-blockers + PTU + IV Potassium Iodide (Lugol's solution, given 1 hour AFTER PTU to block organification via Wolff-Chaikoff effect) + IV Hydrocortisone.
Adrenal Axis Pathologies
Adrenal Insufficiency (Addison's Disease - Primary): Autoimmune destruction of adrenal cortex. Loss of cortisol and aldosterone. Clinical features: Hypotension, hyponatremia, hyperkalemia, fatigue, and hyperpigmentation (elevated ACTH stimulates melanocytes via MSH co-secretion). Diagnosis: 8 AM Cortisol (low) followed by Cosyntropin (synthetic ACTH) Stimulation Test (failure of cortisol to double confirms primary AI). Treatment: Hydrocortisone + Fludrocortisone.
Cushing's Syndrome (Hypercortisolism): Features: Moon facies, buffalo hump, abdominal striae, hypertension, hyperglycemia, proximal muscle weakness. Diagnostic Workup: Screening via 24h Urine Free Cortisol or Overnight 1mg Dexamethasone Suppression Test (failure to suppress cortisol <1.8 mcg/dL confirms hypercortisolism). Next step: Plasma ACTH (Low = Adrenal adenoma; High = ACTH-dependent: Pituitary adenoma vs. Ectopic SCLC).
Pheochromocytoma: Catecholamine-secreting tumor of adrenal medulla chromaffin cells. Triad: Episodic Headaches, Sweating, Tachycardia + Severe Hypertension. Diagnosis: Plasma free metanephrines or 24h urinary fractionated metanephrines. Management: Alpha-blocker FIRST (Phenoxybenzamine) for 10-14 days before surgery; then add Beta-blocker. (Never give Beta-blocker first; causes unopposed alpha-1 stimulation leading to hypertensive crisis!).
Osteoporosis
Osteoporosis is a skeletal disorder of low bone mass and microarchitectural deterioration that increases fracture risk; the SMLE tests screening and first-line therapy in postmenopausal women and chronic-steroid users.
Screening: DEXA scan at age ≥65 for women and ≥70 for men, or earlier with risk factors (chronic glucocorticoid use, early menopause, low body weight, smoking, family history of hip fracture). A T-score ≤ −2.5 defines osteoporosis; −1.0 to −2.5 is osteopenia.
Treatment: First-line is a bisphosphonate (alendronate); ensure adequate calcium (1,000–1,200 mg/day) and vitamin D (800–1,000 IU/day). For glucocorticoid-induced osteoporosis, start bisphosphonate prophylaxis concurrently with chronic steroids.
Saudi relevance: Despite a sunny climate, vitamin D deficiency is highly prevalent in Saudi Arabia, driven by limited skin sun exposure and an indoor lifestyle; a low serum 25-OH-D is a modifiable risk factor emphasized on the exam.